PT - JOURNAL ARTICLE AU - Schoisswohl, Stefan AU - Basso, Laura AU - Simoes, Jorge AU - Engelke, Milena AU - Langguth, Berthold AU - Mazurek, Birgit AU - Lopez-Escamez, Jose Antonio AU - Kikidis, Dimitrios AU - Cima, Rilana AU - Bernal-Robledano, Alberto AU - Boecking, Benjamin AU - Bulla, Jan AU - Cederroth, Christopher R. AU - Crump, Holger AU - Denys, Sam AU - Escalera-Balsera, Alba AU - Gallego-Martinez, Alvaro AU - Gallus, Silvano AU - Goedhart, Hazel AU - Hidalgo-Lopez, Leyre AU - Jarach, Carlotta M. AU - Kader, Hafez AU - Koller, Michael AU - Lugo, Alessandra AU - Marcrum, Steven C. AU - Markatos, Nikos AU - Martin-Lagos, Juan AU - Martinez-Martinez, Marta AU - Muller-Locatelli, Nicolas AU - Neff, Patrick AU - Niemann, Uli AU - Perez-Carpena, Patricia AU - Pryss, Rüdiger AU - Puga, Clara AU - Robles-Bolivar, Paula AU - Rose, Matthias AU - Schecklmann, Martin AU - Schiele, Tabea AU - Schleicher, Miro AU - Schobel, Johannes AU - Spiliopoulou, Myra AU - Stark, Sabine AU - Staudinger, Susanne AU - Stege, Alexandra AU - Toedtli, Beat AU - Trochidis, Ilias AU - Unnikrishnan, Vishnu AU - Vassou, Evgenia AU - Verhaert, Nicolas AU - Vogel, Carsten AU - Zachou, Zoi AU - Schlee, Winfried TI - Single versus Combination Treatment in Tinnitus: An International, Multicentre, Parallel-arm, Superiority, Randomised Controlled Trial AID - 10.1101/2024.01.09.24300978 DP - 2024 Jan 01 TA - medRxiv PG - 2024.01.09.24300978 4099 - http://medrxiv.org/content/early/2024/08/13/2024.01.09.24300978.short 4100 - http://medrxiv.org/content/early/2024/08/13/2024.01.09.24300978.full AB - Tinnitus is associated with a variety of aetiologies, phenotypes, and underlying pathophysiological mechanisms, and available treatments have limited efficacy. A combination of treatments, addressing various aspects of tinnitus, might provide a viable and superior treatment strategy.In this international multicentre, parallel-arm, superiority, randomised controlled trial, patients with chronic subjective tinnitus were recruited from five clinical sites across the EU as part of the interdisciplinary collaborative UNITI project. Patients were randomly assigned using a web-based system, stratified by their hearing and distress level, to single or combination treatment of 12 weeks. Cognitive-behavioural therapy, hearing aids, structured counselling, and sound therapy were administered either alone or as a combination of two treatments resulting in ten treatment arms. The primary outcome was the difference in the change from baseline to week 12 in the total score of the Tinnitus Handicap Inventory (THI) between single and combination treatments in the intention-to-treat population. All statistical analysis were performed blinded to treatment allocation.674 patients of both sexes aged between 18 and 80 years were screened for eligibility. 461 participants (190 females) with chronic subjective tinnitus and at least mild tinnitus handicap were enrolled, 230 of which were randomly assigned to single and 231 to combination treatment. Least-squares mean changes from baseline to week 12 were -11.7 for single treatment (95% confidence interval [CI], -14.4 to -9.0) and -14.9 for combination treatments (95% CI, -17.7 to -12.1), with a statistically significant group difference (p=0.034). Cognitive-behavioural therapy and hearing aids alone had large effect sizes, which could not be further increased by combination treatment. No serious adverse events occurred.In this trial involving patients with chronic tinnitus, all treatment arms showed improvement in THI scores from baseline to week 12. Combination treatments showed a stronger clinical effect than single treatment, however, no clear synergistic effect was observed when combining treatments. We observed rather a compensatory effect, where a more effective treatment offsets the clinical effects of a less effective treatment.ClinicalTrials.gov Identifier: NCT04663828.Competing Interest StatementDetails on competing interest can be found in the preprint.Clinical TrialNCT04663828Clinical Protocols https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-021-05835-z https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-023-07303-2 Funding StatementThis clinical trial received funding from the European Unions Horizon 2020 Research and Innovation Program (grant agreement number 848261)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was independently approved by the following ethics committees: University of Regensburg, Regensburg, Germany (combined ethical approval for clinical sites Berlin and Regensburg); Katholieke Universiteit Leuven, Leuven, Belgium; Ethniko Kai Kapodistriako Panepistimo Athinon, Athens, Greece; Hospital Universitario Virgen de las Nieves/ Hospital Clinico Universitario San Cecilio, Granada, Spain.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesDe-identified data generated from this trial will initially be available only on request for researchers to reproduce results, later publicly via ZENODO. Current data availability will be reported on the UNITI website (https://uniti.tinnitusresearch.net/).